Estimating outcomes and cost effectiveness using a single-arm clinical trial: ofatumumab for double-refractory chronic lymphocytic leukemia

por Hatswell, Anthony J., Thompson, Gwilym J., Maroudas, Penny A., Sofrygin, Oleg, Delea, Thomas E.
Publicado 2017